Teva launches Rituxan biosimilar in U.S.
https://seekingalpha.com/news/3568193-teva-launches-rituxan-biosimilar-in-u-s?source=feed_sector_healthcare
May 04, 2020 - Teva Pharmaceutical Industries (NYSE:TEVA) and collaboration partner Celltrion Healthcare announce the commercial availability of Truxima (rituximab-abbs), a biosimilar to Roche's (OTCQX:RHHBY) Rituxa
0
Teva Pharmaceutical Industries Ltd. (TEVA) Gains As Market Dips: What You Should Know
http://www.zacks.com/stock/news/897134/teva-pharmaceutical-industries-ltd-teva-gains-as-market-dips-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-897134
Apr 28, 2020 - In the latest trading session, Teva Pharmaceutical Industries Ltd. (TEVA) closed at $10.84, marking a +1.12% move from the previous day.
0
Eagle Pharma and Teva prevail in Bendeka patent challenge
https://seekingalpha.com/news/3565267-eagle-pharma-and-teva-prevail-in-bendeka-patent-challenge?source=feed_sector_healthcare
Apr 28, 2020 - Eagle Pharmaceuticals (NASDAQ:EGRX) and licensee Teva Pharmaceutical Industries (NYSE:TEVA) announce a favorable outcome in a patent dispute from would-be generic competitors to blood cancer med Bende
0
Teva launches Ajovy autoinjector in U.S.
https://seekingalpha.com/news/3564611-teva-launches-ajovy-autoinjector-in-u-s?source=feed_sector_healthcare
Apr 27, 2020 - Teva Pharmaceutical Industries (NYSE:TEVA) announces the availability of the autoinjector device for migraine med Ajovy (fremanezumab-vfrm) at a wholesale acquisition cost (WAC) of $603.20.The
0
Is a Beat in Store for Perrigo (PRGO) This Earnings Season?
http://www.zacks.com/stock/news/891904/is-a-beat-in-store-for-perrigo-prgo-this-earnings-season?cid=CS-ZC-FT-analyst_blog|earnings_preview-891904
Apr 27, 2020 - Perrigo's (PRGO) Consumer Self Care Americas segment is expected to have aided the company's top line in the soon-to-be-reported quarter.
0
2 Crazy-Cheap Buffett Stocks to Buy Now
https://www.fool.com/investing/2020/04/13/2-crazy-cheap-buffett-stocks-to-buy-now.aspx?source=iedfolrf0000001
Apr 13, 2020 - Berkshire Hathaway and Teva Pharmaceutical Industries Ltd. are absurdly cheap right now.
0
Teva Pharmaceutical Industries Ltd. (TEVA) Gains As Market Dips: What You Should Know
http://www.zacks.com/stock/news/859627/teva-pharmaceutical-industries-ltd-teva-gains-as-market-dips-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-859627
Apr 07, 2020 - Teva Pharmaceutical Industries Ltd. (TEVA) closed at $9.54 in the latest trading session, marking a +0.85% move from the prior day.
0
UBS still bullish on Teva despite trimming fair value target; shares up 9%
https://seekingalpha.com/news/3558659-ubs-still-bullish-on-teva-despite-trimming-fair-value-target-shares-up-9?source=feed_sector_healthcare
Apr 06, 2020 - In a note, UBS reiterates its Buy rating on Teva Pharmaceutical Industries (TEVA +8.5%) albeit with a revised price target of $12 (from $14).Analyst Kevin Caliendo believes the company is relatively i
0
3 Warren Buffett Stocks I Absolutely, Positively Wouldn't Buy Right Now
https://www.fool.com/investing/2020/04/05/3-warren-buffett-stocks-i-absolutely-positively-wo.aspx?source=iedfolrf0000001
Apr 05, 2020 - The Oracle of Omaha owns some fantastic stocks in his Berkshire Hathaway portfolio. These aren't in the group.
0
Teva prevails in migraine patent dispute with Lilly; shares up 9%
https://seekingalpha.com/news/3556858-teva-prevails-in-migraine-patent-dispute-lilly-shares-up-9?utm_source=feed_news_all&utm_medium=referral
Mar 31, 2020 - The USPTO's Patent Trial and Appeal Board has upheld three patents protecting Teva Pharmaceutical Industries' (TEVA +9.0%) migraine med Ajovy (fremanezumab-vfrm) that were challenged by Eli Lilly (LLY
0
Pages: 12
Page 1